Lynch, Rebecca M <br/><br/>
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection.  [electronic resource] 

 -  Science translational medicine  12 2015 
 - 319ra206 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1946-6242 
<br/><br/><label>Standard No.: </label>10.1126/scitranslmed.aad5752  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Neutralizing--administration & dosage<br/>Antiretroviral Therapy, Highly Active<br/>CD4-Positive T-Lymphocytes--immunology<br/>Chronic Disease<br/>HIV Antibodies--blood<br/>HIV Infections--blood<br/>HIV-1--immunology<br/>Humans<br/>Kinetics<br/>Middle Aged<br/>Viral Load--immunology<br/>Young Adult